Aconitase: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
'''Aconitase (ACO)''' is an enzymatic domain that confers the ability to catalyse the equilibrium
:citrate = aconitate + H<sub>2</sub>O = isocitrate
This reaction is part of the citrate (TCA-, Krebs-cycle).
In most organims, there is a cytosolic enzyme with an ACO domain (cAc), and in metazoa and up, a second copy was forked in mitochondria (mAc). A specialty of cAc is that in mammals it has developed a second function as inhibitor of those mRNA that carry an iron-regulatory element (IRE). Therefore, the cytosolic cAc is named IREBP for IRE-binding protein when this function is talked about. Only one of the two functions is active, depending on whether the (4Fe4S) cofactor is present in the molecule: it's essential for the ACO function.
== Available structures ==
In the PDB, nearly all deposited structures are from mammals, [[1l5j]] is from ''E.coli''. Also, only [[2ipy]] shows the IREBP function of cAc---it's also the only from rabbit. There are only two other cAc structures, with and without citrate, also the only from human. All other structures are either cow or pig, and a mutant from pig; all three proteins with several different ligands and inhibitors.
*[[1aco]] - mAc (''Bos taurus'') with ''trans''-aconitate (inhibitor)
*[[1aco]] - mAc (''Bos taurus'') with ''trans''-aconitate (inhibitor)
*[[1ami]] - mAc (''Bos taurus'') with methylisocitrate
*[[1ami]] - mAc (''Bos taurus'') with methylisocitrate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Ralf Stephan, Eran Hodis, Anthony Noles, Alexander Berchansky, David Canner, Jaime Prilusky, Michal Harel, Joel L. Sussman, Angel Herraez